gemtuzumab ozogamicin (mylotarg) Report issue

Biologics mAb ADC Orphan Drug FDA Approved FDA Accelerated Approval FDA Priority Review FDA

Active Ingredient History

NOW
  • Now
Gemtuzumab ozogamicin, sold under the brand name Mylotarg, is an antibody-drug conjugate that is used to treat acute myeloid leukemia.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Payload: calicheamicin
  • Black Box: Yes
  • Availability: Missing data
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$6483.4800 - $8327.0400
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

cdp-771 | cma 676 | cma-676 | cmc-676 | gemtuzumab | gemtuzumab ozogamicin | gemtuzumab-ozogamicin | gemtuzumab ozogamycin | mylotarg | way-cma-676

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue